10 news items
Takeda Presents Long-Term Data from Phase 3 ADVANCE-CIDP 3 Clinical Trial of HYQVIA® in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) at PNS Annual Meeting
TAK
18 Jun 24
, on Takeda and its customers and suppliers, including foreign governments in countries in which Takeda operates, or on other facets of its business
Takeda Announces Phase 3 Topline Results for Soticlestat (TAK-935) in Patients with Dravet Syndrome and Lennox-Gastaut Syndrome
TAK
17 Jun 24
the novel coronavirus pandemic, on Takeda and its customers and suppliers, including foreign governments in countries in which Takeda operates
Takeda Signs Option Agreement with Ascentage Pharma to Enter into Exclusive Global License for Olverembatinib, a Third-Generation BCR-ABL Tyrosine Kinase Inhibitor (TKI)
TAK
14 Jun 24
the novel coronavirus pandemic, on Takeda and its customers and suppliers, including foreign governments in countries in which Takeda operates, or on other
HEALWELL AI's Pentavere Announces Partnership with Takeda to Support Rare Disease Real-World Evidence Analysis for Patients living with Hereditary Angioedema
TAK
6 Jun 24
; the effects of competition in the industry; the requirement for increasingly innovative product solutions and service offerings; trends in customer growth
Takeda's TAK-861 Phase 2b Late-Breaking Data Presentations at SLEEP 2024 Demonstrate Clinically Meaningful Impact of Oral Orexin Agonist in Narcolepsy Type 1 Compared to Placebo
TAK
3 Jun 24
crises, like the novel coronavirus pandemic, on Takeda and its customers and suppliers, including foreign governments in countries in which Takeda
8n4yoy70z5rjbkk d1htkz
PFE
TAK
1 Jun 24
of marketed products or product candidates; the impact of health crises, like the novel coronavirus pandemic, on Takeda and its customers and suppliers
n7cb9gjxfs4m9ofkm2z2ukxvohfop5aonleyl47xzsntry8qp2s
TAK
31 May 24
, on Takeda and its customers and suppliers, including foreign governments in countries in which Takeda operates, or on other facets of its business
egarv2hqrcx8bd9 iavaplvvh5qxjmqj9dhgv
TAK
26 Apr 24
coronavirus pandemic, on Takeda and its customers and suppliers, including foreign governments in countries in which Takeda operates, or on other
jtdywv0cbq38n6yamj9cnwpf2vjitudl05k36emctrndoxhk6j
TAK
22 Apr 24
) the inability of Astellas to continue to effectively research and develop products accepted by customers in highly competitive markets, and (vi
8koqxw4jrtqlflvur80fwzv5w
TAK
18 Apr 24
of health crises, like the novel coronavirus pandemic, on Takeda and its customers and suppliers, including foreign governments in countries in which
- Prev
- 1
- Next